SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                  FORM 10-QSB

(Mark One)

|X|      QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (D) OF THE SECURITIES
         EXCHANGE ACT OF 1934

                For the quarterly period ended September 30, 2007

                                       OR

|_|      TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (D) OF THE SECURITIES
         EXCHANGE ACT OF 1934

    For the transition period from ___________________ to ___________________

                       MEDICAL CONNECTIONS HOLDINGS, INC.
                       ----------------------------------
             (Exact name of registrant as specified in its charter)

          Florida                      333-72376              65-0920373
          -------                      ---------              ----------
(State or other jurisdiction of       Commission          (I.R.S. Employer
incorporation or organization)         File No.          Identification No.)

                          2300 Glades Road Suite 202 E
                           Boca Raton, Florida 33431
                           -------------------------
               (Address of principal executive office)(Zip Code)

                                 (561) 353-1110
                                 --------------
              (Registrant's telephone number, including area code)

                                       N/A
                                       ---
               Former name, former address and former fiscal year,
                          if changed since last report.

Indicate by a check mark whether the registrant (1) has filed all reports
required to be filed by Section 13 or 15 (d) of the Securities Exchange Act of
1934 during the preceding 12 months (or for such shorter period that the
registrant was required to file such reports), and (2) has been subject to such
filing requirements for the past 90 days.

Yes |X|     No |_|

Indicate by a check mark whether the registrant is an accelerated filer (as
defined in Rule 12b-2 of the Exchange Act).

Yes |_|     No |X|

                      APPLICABLE ONLY TO CORPORATE ISSUERS:

Indicate the number of shares outstanding of each of the issuer's classes of
Common Stock as of the latest practicable date:

    15,977,298 shares of Common Stock, $.001 par value as of October 31, 2007

<PAGE>
                                      INDEX

                         PART I. - FINANCIAL INFORMATION

Item 1. Financial Statements

         Condensed Consolidated Balance Sheet as at September 30, 2007
         (unaudited)

         Condensed Consolidated Statements of Operations for the Nine and Three
         Months Ended September 30, 2007 and September 30, 2006 (unaudited)

         Condensed Consolidated Statements of Cash Flows for the Nine Months
         Ended September 30, 2007 and September 30, 2006 (unaudited)

         Notes to Condensed Consolidated Financial Statements as of September
         30, 2007 (unaudited)

Item 2. Management's Discussion and Analysis of Financial Condition and
        Results of Operations

Item 3. Controls and Procedures

                          PART II. - OTHER INFORMATION

Item 1. Legal Proceedings

Item 2. Unregistered Sales of Equity Securities

Item 3. Defaults upon senior securities

Item 4. Submission of matters to a vote of security holders

Item 5. Other information

Item 6. Exhibits and report on Form 8-K

                                       2
<PAGE>
                         PART I. FINANCIAL INFORMATION

Item 1. Financial Statements

               MEDICAL CONNECTIONS HOLDINGS, INC. AND SUBSIDIARIES
                      CONDENSED CONSOLIDATED BALANCE SHEET
                                   (UNAUDITED)
                               September 30, 2007
<TABLE>
<S>                                                                            <C>
                                     ASSETS

CURRENT ASSETS
    Cash and cash equivalents                                                  $  1,313,072
    Accounts receivable, net                                                        493,729
                                                                               ------------
         Total current assets                                                     1,806,801
                                                                               ------------

PROPERTY AND EQUIPMENT
    Property and equipment                                                          270,920
    Less: accumulated depreciation                                                 (119,671)
                                                                               ------------
         Net property and equipment                                                 151,249
                                                                               ------------
OTHER ASSETS
    Investment property                                                             647,432
    Security deposit                                                                 28,540
                                                                               ------------
TOTAL ASSETS                                                                   $  2,634,022
                                                                               ============

                 LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)

CURRENT LIABILITIES
    Accounts payable and accrued expenses                                      $    284,294
    Convertible debentures, net                                                   2,581,005
    Fair value derivative                                                           466,211
    Liability for stock to be issued                                                 65,056
                                                                               ------------
         Total current liabilities                                                3,396,566
                                                                               ------------
LONG-TERM LIABILITIES
   Mortgage payable                                                                 459,452
                                                                               ------------
         Total liabilities                                                        3,856,018
                                                                               ------------
STOCKHOLDERS' EQUITY (DEFICIT)
   Preferred stock, Class A, $.001 par value; 5,000,000 shares authorized,
     165,573 issued and outstanding                                                     166
   Preferred stock, Calss B, $.001 par value; 5,000,000 shares authorized,
     1,000,000 issued and outstanding                                                 1,000
   Common stock, $.001 par value, 25,000,000 shares authorized,
     14,107,881 shares issued and outstanding                                        14,108
   Additional paid-in capital                                                    14,979,633
   Accumulated deficit                                                          (16,216,902)
                                                                               ------------
         Total stockholders' equity (deficit)                                    (1,221,995)
                                                                               ------------
TOTAL LIABILITIES AND STOCKHOLDERS'  EQUITY (DEFICIT)                          $  2,634,022
                                                                               ============
</TABLE>

              The accompanying notes are an integral part of these
                  condensed consolidated financial statements

                                       3
<PAGE>
              MEDICAL CONNECTIONS HOLDINGS, INC. AND SUBSIDIARIES
                CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
                                  (UNAUDITED)
<TABLE>
<CAPTION>
                                                             NINE MONTHS ENDED                  THREE MONTHS ENDED
                                                               SEPTEMBER 30,                       SEPTEMBER 30,
                                                          2007              2006              2007              2006
                                                      ------------      ------------      ------------      ------------
<S>                                                   <C>               <C>               <C>               <C>
REVENUES                                              $  3,255,643      $  1,415,487      $  1,176,850      $    745,635
                                                      ------------      ------------      ------------      ------------
OPERATING EXPENSES
   Advertising and marketing                               278,173           154,102            93,311            60,271
   Administrative and other                                452,643           184,175           178,183            85,271
   Staffing compensation & relocation expense            1,842,687           439,086           642,597           302,135
   Depreciation                                             49,051            38,080            18,465            13,540
   Outside services                                        117,286            35,272            42,127            14,310
   Payroll                                               3,570,784         1,940,713         1,119,937           633,539
   Professional fees                                       415,127            97,563           297,512            28,796
   Rent                                                    122,735            89,024            59,070            25,518
   Telephone                                                62,969            58,805            22,165            19,858
   Travel and entertainment                                118,292            73,083            29,627            21,454
                                                      ------------      ------------      ------------      ------------
          Total operating expenses                       7,029,747         3,109,903         2,502,995         1,204,692
                                                      ------------      ------------      ------------      ------------
NET OPERATING LOSS                                      (3,774,104)       (1,694,416)       (1,326,145)         (459,057)
                                                      ------------      ------------      ------------      ------------
OTHER INCOME (EXPENSE)
         Gain (loss)on revaluation of derivatives          121,339                --          (189,397)               --
         Interest expense                                 (797,178)         (243,311)         (305,804)         (159,919)
         Interest income                                    15,237               554             9,829               297
         Rental income                                          --            13,100                --             5,900
                                                      ------------      ------------      ------------      ------------
          Total other income/(expense)                    (660,602)         (229,657)         (485,372)         (153,722)
                                                      ------------      ------------      ------------      ------------
NET (LOSS) BEFORE
PROVISION FOR INCOME TAXES                              (4,434,706)       (1,924,073)       (1,811,516)         (612,780)
         Provision for income taxes                             --                --                --                --
                                                      ------------      ------------      ------------      ------------
NET LOSS                                              $ (4,434,706)     $ (1,924,073)     $ (1,811,516)     $   (612,780)
                                                      ============      ============      ============      ============
BASIC LOSS PER SHARE                                  $      (0.46)     $      (2.22)     $      (0.15)     $      (0.25)
                                                      ============      ============      ============      ============
BASIC WEIGHTEDAVERAGE NUMBER
   OF COMMON SHARES                                      9,601,531           865,551        11,949,111         2,480,178
                                                      ============      ============      ============      ============
</TABLE>

              The accompanying notes are an integral part of these
                   condensed consolidated financial statements

                                       4
<PAGE>
               MEDICAL CONNECTIONS HOLDINGS, INC. AND SUBSIDIARIES
                 CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
                                   (UNAUDITED)
<TABLE>
<CAPTION>
                                                              NINE MONTHS ENDED
                                                               SEPTEMBER 30,
                                                           2007              2006
                                                        -----------      -----------
<S>                                                     <C>              <C>
CASH FLOW FROM OPERATING ACTIVITIES
   Net (loss)                                           $(4,434,706)     $(1,924,073)
                                                        -----------      -----------
Adjustments to reconcile net (loss) to net cash
(used in) operating activities:
   Amortization of debt discount                            486,449               --
   Increase in fair value derivative                        262,060               --
   Depreciation                                              49,051           38,080
   Common stock issued for interest expense                      --          223,272
   Common stock issued for compensation                     418,000          245,000
Changes in assets and liabilities
   Accounts receivable                                     (254,851)        (262,156)
   Security deposit                                              --            4,703
   Accounts payable and accrued expenses                    221,373           11,063
                                                        -----------      -----------
          Total adjustments                               1,182,082          259,962
                                                        -----------      -----------
          Net cash (used in) operating activities        (3,252,625)      (1,664,111)
                                                        -----------      -----------
CASH FLOW FROM INVESTING ACTIVITIES
   Acquisition of property and equipment                    (75,726)         (26,176)
                                                        -----------      -----------
          Net cash (used in) investing activities           (75,726)         (26,176)
                                                        -----------      -----------
CASH FLOW FROM FINANCING ACTIVITIES
   Increase in mortgage payable                                  --            9,000
   Proceeds from issuance of common stock                 2,511,973               --
   Decrease in line of credit - Regions Bank                (47,810)              --
   Payment on promissory note                               (40,000)         (19,196)
   Proceeds from issuance of convertible debentures       2,136,009        1,192,560
   Proceeds from loan payable                                    --          100,000
   Payment on loan payable                                       --          (25,000)
   Liability for stock to be issued                         (15,002)         712,964
                                                        -----------      -----------
          Net cash provided by financing activities       4,545,170        1,970,328
                                                        -----------      -----------
NET INCREASE IN CASH AND CASH
   EQUIVALENTS                                            1,216,820          280,041

CASH AND CASH EQUIVALENTS
   -BEGINNING OF PERIOD                                      96,252          107,657
                                                        -----------      -----------
CASH AND CASH EQUIVALENTS
   - END OF PERIOD                                      $ 1,313,072      $   387,698
                                                        ===========      ===========
</TABLE>

              The accompanying notes are an integral part of these
                   condensed consolidated financial statements

                                       5
<PAGE>
               MEDICAL CONNECTIONS HOLDINGS, INC. AND SUBSIDIARIES
                 CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
                                   (UNAUDITED)
<TABLE>
<CAPTION>
                                                               NINE MONTHS ENDED
                                                                 SEPTEMBER 30,
                                                             2007            2006
                                                         ------------     -----------
<S>                                                      <C>              <C>
SUPPLEMENTAL DISCLOSURE OF CASH FLOW
 INFORMATION:
    Cash paid during the period for:
      Interest                                           $     47,405     $    21,506
                                                         ============     ===========
SUPPLEMENTAL DISCLOSURE OF NON-CASH
   INFORMATION:

    Common stock issued for interest expense             $     45,153     $   223,272
                                                         ============     ===========
    Common stock issued for compensation                 $    418,000     $   245,000
                                                         ============     ===========
    Common stock issued for debt conversion              $    752,560     $   870,000
                                                         ============     ===========
    Common stock issued for liability                    $         --     $   875,028
                                                         ============     ===========
    Common stock dividend issued in preferred shares     $  2,650,513     $10,299,520
                                                         ============     ===========
    at a conversion rate of 1 preferred share
    to 19 common stock shares - 6,975,033 shares
</TABLE>

                                       6
<PAGE>
              MEDICAL CONNECTIONS HOLDINGS, INC., AND SUBSIDIARIES
              NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
                               SEPTEMBER 30, 2007

NOTE 1 - ORGANIZATION AND BASIS OF PRESENTATION

         Medical Connections Holdings, Inc. (f/k/a Webb Mortgage Depot, Inc.)
was incorporated in the state of Florida on May 11, 1999. It was organized to
implement a corporate reorganization of Webb Mortgage Corp. and Webb Mortgage
Services Corporation, companies that were formed by our former C.E.O. At that
time we operated as a mortgage broker and generated revenues by originating
mortgage loans that were funded by third parties. We are no longer in the
mortgage business.

         On December 27, 2005, we closed on a share for share exchange agreement
with Medical Connections, Inc. in connection therewith, our prior officers and
directors tendered their resignation and, officers and directors of Medical
Connections Inc., became officers and directors of Medical Connections Holdings,
Inc. The exchange agreement provided, in part, for us to acquire all of the
issued and outstanding shares of capital stock of Medical Connections, Inc., a
Florida corporation, in exchange for shares of common stock of Webb Mortgage
that would aggregate approximately 95%, of our issued and outstanding common
stock. In connection with the closing of this transaction, our Board of
Directors on January 3, 2006 authorized a 100:1 reverse split of our common
stock effective for the shareholders of record on January 20, 2006.

         We also redeemed the 1,831,000 shares of our common stock which were
owned by our former president and chief executive officer, in exchange for the
payment of $200,000 by Medical Connections. We were required to issue to the
Medical Connections shareholders a total of 476,880 shares of our common stock
in connection with this transaction. Also, on December 14, 2005 we filed a
certificate of amendment to our articles of incorporation with the Florida
Secretary of State changing our name to Medical Connections Holdings, Inc.
Additionally, in this transaction, the Company acquired title to a single family
residence, which is primarily held for investment purposes.

         Medical Connections Holdings, Inc., and subsidiaries, (the "Company")
is an employment and executive search firm that provides recruiting services to
its clients within the healthcare and medical industries. The Company was formed
in Florida on November 26, 2002 for the purpose of specializing in the
recruitment and placement of healthcare professionals in a variety of employment
settings, generally, working thirteen week contracts.

         Our common stock trades on the NASDAQ OTC B/B as a fully reporting
company under the ticker symbol MCTH.

         The condensed consolidated unaudited financial statements included
herein have been prepared, pursuant to the rules and regulations of the
Securities and Exchange Commission. The condensed consolidated financial
statements and notes are presented as permitted on Form 10-QSB and do not
contain information included in the Company's annual consolidated statements and
notes. For further information, these financial statements and related notes
should be read in conjunction with the Company's audited financial statements
for the year ended December 31, 2006 and the accompanying notes thereto. Certain
information and footnote disclosures normally included in financial statements
prepared in accordance with accounting principles generally accepted in the
United States of America have been condensed or omitted pursuant to such rules
and regulations, although the Company believes that the disclosures are adequate
to make information presented not misleading. The results of the nine months
ended September 30, 2007 may not be indicative of the results for the entire
year.

         These condensed consolidated unaudited financial statements reflect all
adjustments, consisting of normal recurring adjustments, which in the opinion of
management are necessary for fair presentation of the information contained
herein.

                                       7
<PAGE>

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

PRINCIPLES OF CONSOLIDATION

         The condensed consolidated balance sheet for September 30, 2007 and
condensed consolidated statements of operations and cash flows for the nine
months ended September 30, 2007 and 2006 includes Medical Connections Holdings,
Inc., and its wholly owned subsidiaries. Intercompany transactions and balances
have been eliminated in consolidation.

USE OF ESTIMATES

         The preparation of consolidated financial statements in conformity with
accounting principles generally accepted in the United States of America
requires management to make estimates and assumptions that affect the amounts
reported in the consolidated financial statements and accompanying notes. Actual
results could differ from those estimates.

ADVERTISING

         The Company's policy is to expense advertising and marketing costs as
they are incurred. Advertising expense, for the nine months ended, September 30,
2007 and 2006, was $278,173 and $154,102, respectively. Advertising expense, for
the three months ended, September 30, 2007 and 2006, was $ 93,311 and $ 60,271
respectively.

INCOME TAXES

         Effective January 1, 2007, we adopted Financial Accounting Standard
Board ("FASB") Interpretation No. ("FIN") 48, "Accounting for Uncertainty in
Income Taxes," or "FIN 48," which clarifies the accounting for uncertainty in
income taxes recognized in the financial statements in accordance with Statement
of Financial Accounting Standards ("SFAS") No. 109, "Accounting for Income
Taxes," or "SFAS No. 109." We utilize a recognition threshold and measurement
attribute for the financial statement recognition and measurement of a tax
position taken or expected to be taken in a tax return.

RECLASSIFICATIONS

         Certain amounts at September 30, 2006 were reclassified to conform to
the 2007 presentation. These reclassifications had no effect on net loss for the
periods presented.

STOCK-BASED COMPENSATION

         In December 2004, the FASB issued Financial Accounting Standard No.
123R (revised 2004) (FAS 123R), "Share-Based Payment, "FAS 123R replaces FAS No.
123, "Accounting for Stock-Based Compensation", and supersedes APB Opinion No.
25, "Accounting for Stock Issued to Employees." FAS 123R requires compensation
expense, measured as the fair value at the grant date, related to share-based
payment transactions to be recognized in the financial statements over the
period that an employee provides service in exchange for the award. The Company
adopted FAS 123R using the "modified prospective" transition method as defined
in FAS 123R. Under the modified prospective method, companies are required to
record compensation cost prospectively for the unvested portion, as of the date
of adoption, of previously issued and outstanding awards over the remaining
vesting period of such awards. FAS 123R was effective January 1, 2006.

         The Company measures compensation expense for its non-employee
stock-based compensation under the Financial Accounting Standards Board (FASB)
Emerging Issues Task Force (EITF) Issue No. 96-18, "Accounting for Equity
Instruments that are Issued to Other Than Employees for Acquiring, or in
Conjunction with Selling, Goods or Services". The fair value of the option
issued is generally used to measure the transaction, as this is more reliable
than the fair value of the services received. The fair value is measured at the
value of the Company's common stock on the date that the commitment for
performance by the counterparty has been reached or the counterparty's
performance is complete. The fair value of the equity instrument is charged
directly to compensation expense and additional paid-in capital.

                                       8
<PAGE>

FAIR VALUE OF FINANCIAL INSTRUMENTS

         The carrying amount reported in the balance sheet for cash and cash
equivalents and liability for stock to be issued approximate fair value because
of the short-term maturity of these financial instruments.

EARNINGS (LOSS) PER SHARE OF COMMON STOCK

         Net income (loss) per common share is computed using the weighted
average number of common shares outstanding. Diluted earnings per share (EPS)
include additional dilution from common stock equivalents, such as stock
issuable pursuant to the exercise of stock options and warrants. There were no
such options or warrants affecting the earnings per share for the nine and three
months ended September 30, 2007 and 2006, respectively. Common stock equivalents
were not included in the computation of diluted earnings per share when the
Company reported a loss because to do so would be antidilutive for periods
presented.

RECENT ACCOUNTING PRONOUNCEMENTS

         SFAS No. 159, "The Fair Value Option for Financial Assets and Financial
Liabilities-Including an amendment of FASB Statement No. 115." SFAS 159 permits
entities to choose to measure eligible items at fair value at specified election
dates. Unrealized gains and losses on items for which the fair value option has
been elected are reported in earnings at each subsequent reporting date. The
fair value option (i) may be applied instrument by instrument, with certain
exceptions, (ii) is irrevocable (unless a new election date occurs) and (iii) is
applied only to entire instruments and not to portions of instruments. SFAS 159
is effective for the Corporation on January 1, 2008 and is not expected to have
a significant impact on the Company's financial statements.

NOTE 3 - ACCOUNTS RECEIVABLE

         We factor our accounts receivable for contract (travel) invoices. Wells
Fargo Business Services purchases some of our contract (travel) invoices,
initially for 90% of the invoice price, sending a wire transfer within 48 hours,
which helps our liquidity, and cash flow. The remaining 10 % is part of a
reserve, in which the Company receives part of the 10%, depending upon Wells
Fargo's costs related to collections of accounts receivable. Our accounts
receivable, for the permanent and women's health (REI) divisions, of our
company, are collected 100% in-house, and are not factored.

NOTE 4 - LIABILITY FOR STOCK TO BE ISSUED

         As of September 30, 2007, the Company has received $65,056 for the
purchase of its common stock. Upon the issuance of the common stock the
liability will be satisfied.

NOTE 5 - CONVERTIBLE DEBENTURES/DERIVATIVE LIABILITY

         The convertible debentures are callable at the company's option, bear
interest at rates ranging from 6% to 8% and are due on various dates, within 12
months of the date of issue, unless converted into common stock. On September
30, 2007 we issued 1,063,618 shares of our Common Stock to convertible debenture
holders in exchange for $797,713 of debt and interest. In accordance with
Statement of Financial Accounting Standards No. 133, `Accounting for Derivative
Instruments and Hedging Activities', ("FASB 133"), we determined that the
conversion feature of the convertible debentures met the criteria of an embedded
derivative and therefore the conversion feature of the debt needed to be
bifurcated and accounted for as a derivative. Due to the reset provisions of the
convertible debentures, the debt does not meet the definition of "conventional
convertible debt" because the number of shares which may be issued upon the
conversion of the debt is not fixed. Therefore, the conversion feature fails to
qualify for equity classification under EITF 00-19, and must be accounted for as
a derivative liability.

         The $2,942,654 face amount of the convertible debentures outstanding as
of September 30, 2007 was stripped of its conversion feature due to the
accounting for the conversion feature as a derivative, which was recorded using
the residual proceeds method, whereby any remaining proceeds after allocating
the proceeds to the warrants and conversion option would be attributed to the
debt. The beneficial conversion feature (an embedded derivative) included in
these convertible debentures resulted in an initial debt discount of $847,163.
At September 30, 2007, we revalued this derivative liability. For the three
months ended September 30, 2007, after adjustment, we recorded a loss on
valuation of derivative liability of $189,397. The associated warrants are
exercisable for 6,763,466 shares of common stock at an exercise price of $1.00

                                       9
<PAGE>

per share. The warrants, which expire on December 31, 2009, were assigned a
value of $301,472, estimated using the Black-Scholes valuation model. The
following assumptions were used to determine the fair value of the warrants
using the Black-Scholes valuation model: a term of 3.5 years, risk-free rate of
between 4.00% and 6.00%, volatility of 40% to 136%, and dividend yield of zero.
In accordance with EITF No. 00-19, and EITF No. 00-27, "Application of Issue No.
98-5 to Certain Convertible Instruments," the values assigned to the debenture,
conversion feature and the warrants were allocated based on their fair values.
The amount allocated as a discount on the convertible debentures for the value
of the warrants and conversion option will be amortized to interest expense,
using the effective interest method, over the term of the convertible
debentures. For the three months ended September 30, 2007, amortization of the
discount on debenture amounted to $187,274 which is included in interest
expense.

The convertible debenture liability is as follows at September 30, 2007:

        Convertible debentures payable               $ 2,942,654
        Less: unamortized discount on debentures        (361,649)
                                                     -----------

        Convertible debentures, net                  $ 2,581,005
                                                     ===========

NOTE 6 - STOCKHOLDERS' EQUITY (DEFICIT)

                  PREFERRED STOCK - A

         As of September 30, 2007, the Company has 5,000,000 shares of its
preferred stock Class A authorized at $0.001 par value and 165,573 issued and
outstanding. Preferred Stock A has a conversion ratio of 1 share to 19 shares of
common stock. For the nine months ended, September 30, 2007, 367,107 preferred
shares of stock have been converted to 6,975,033 shares of common stock.

                  PREFERRED STOCK - B

         As of September 30, 2007, the Company has 5,000,000 shares of its
preferred stock Class B authorized at $0.001 par value and 1,000,000 issued and
outstanding. The stock has super voting powers and is owned equally by our
C.E.O. and President. Holders of the Series B preferred shares shall be entitled
to ten votes per share for each Series B Preferred Share beneficially owned on
all matters brought to a vote of the holders of the Common Stock.

                  COMMON STOCK

         As of September 30, 2007, the Company has 25,000,000 shares of common
stock authorized at $0.001 par value and 13,044,263 issued and outstanding. For
the quarter ended December 31, 2006, the Company had issued 2,542,363 shares of
common stock. Within the first nine months of 2007, the Company has issued
10,501,900 shares of common stock.

         The following details the stock transactions for the three months ended
September 30, 2007:

         The company issued stock to employees and consultants under the
company's stock option plan. In December 2004, the FASB issued Financial
Accounting Standard No. 123R (revised 2004) (FAS 123R), "Share-Based Payment,
"FAS 123R replaces FAS No. 123, "Accounting for Stock-Based Compensation", and
supersedes APB Opinion No. 25, "Accounting for Stock Issued to Employees." FAS
123R requires compensation expense, measured as the fair value at the grant
date, related to share-based payment transactions to be recognized in the
financial statements over the period that an employee provides service in
exchange for the award. The Company adopted FAS 123R using the "modified
prospective" transition method as defined in FAS 123R. Under the modified
prospective method, companies are required to record compensation cost
prospectively for the unvested portion, as of the date of adoption, of
previously issued and outstanding awards over the remaining vesting period of
such awards. FAS 123R was effective January 1, 2006.


                                       10
<PAGE>

         On August 9, 2007 we issued 100,000 shares of our Common Stock to
certain employees for services rendered. The Common Stock was valued at $ 0.38
per share, the fair market value at the date of issuance. A charge of $38,000
has been included in the consolidated statement of operations for the nine
months ended September 30, 2007. The Company relied upon the exemption from
registration contained in Section 4(2), as the recipient was deemed to be
sophisticated with regard to an investment in the Company.

         On September 30, 2007 we issued 1,063,618 shares of our Common Stock to
convertible debenture holders in exchange for $797,713 of debt and interest. At
various dates, during the quarter, we issued a total of 1,697,367 shares, of our
Common Stock, at a price of one dollar per share, with 3,394,734 warrants
exercisable at $ 1.25, and expire December 2010 to accredited investors. The
value of these warrants are included within additional paid-in-capital.

NOTE 7 - PROVISION FOR INCOME TAXES

         The Company accounts for income taxes using the liability method, under
FASB 109. At September 30, 2007 deferred tax assets consist of the following:

                                           2007
                                       -----------
        Deferred tax asset             $ 1,860,822

        Less:  valuation allowance      (1,860,822)
                                       -----------
        Net deferred tax assets        $        --
                                       ===========

         As of September 30, 2007, the Company had net operating loss carry
forwards approximating $4,945,050 available to offset future taxable income
through 2027. The Company established valuation allowances equal to the full
amount of the deferred tax assets due to the uncertainty of the utilization of
the operating losses in future periods. The effective tax rate, for the period
ended September 30, 2007, is 37.63 percent.

         Effective January 1, 2007, we adopted Financial Accounting Standard
Board ("FASB") Interpretation No. ("FIN") 48, "Accounting for Uncertainty in
Income Taxes," or "FIN 48," which clarifies the accounting for uncertainty in
income taxes recognized in the financial statements in accordance with Statement
of Financial Accounting Standards ("SFAS") No. 109, "Accounting for Income
Taxes," or "SFAS No. 109." We utilize a recognition threshold and measurement
attribute for the financial statement recognition and measurement of a tax
position taken or expected to be taken in a tax return.

NOTE 8 - GOING CONCERN

         The accompanying condensed consolidated financial statements have been
prepared in accordance with accounting principals generally accepted in the
United States of America, which contemplates continuation of the Company as a
going concern. The Company has sustained operating losses, and has insufficient
revenues to sustain its operations. These items raise substantial doubt about
the Company's ability to continue as a going concern.

         In view of these matters, realization of the assets of the Company is
dependent upon the Company's ability to meet its financial requirements and the
success of future operations. These consolidated financial statements do not
include adjustments relating to the recoverability and classification of
recorded asset amounts and classification of liabilities that might be necessary
should the Company be unable to continue in existence. The Company's continued
existence is dependent upon its ability to generate sufficient cash flows from
equity financing and revenues.

         In addition, we have relied upon the sale of our stock and debentures
offerings, to fund operations. Through the first nine months, of 2007, we have
raised $ 5,050,275 in cash, through common stock sales of convertible
debentures. We are introducing a $ 5,000,000 PPM to the public, in late
November, as our next stock offering.

                                       11
<PAGE>

         Also, in October, we signed a selected dealer agreement with WestPark
Capital, to issue and sell an offering, on a non-exclusive basis, to raise
capital, of up to 1,000,000 investment units, each consisting of one share of
common stock, and two warrants exercisable at $ 1.25 per share of the Company.
We are also seeking additional firms, to provide the same services as WestPark
Capital.

         We also factor our accounts receivable for contract (travel) invoices.
Wells Fargo Business Services purchases some of our contract (travel) invoices,
initially for 90% of the invoice price, sending a wire transfer within 48 hours,
which helps our liquidity, and cash flow. The remaining 10 % is part of a
reserve, in which the Company receives part of the 10%, depending upon Wells
Fargo's costs related to collections of accounts receivable. We use these funds
for direct operating expenses, as well as general and administrative purposes.

NOTE 9 - CONTINGENCIES

         LEGAL PROCEEDINGS:

         The Company and certain of its subsidiaries are subject to various
pending or threatened legal proceedings arising out of the normal course of
business or operations. In view of the inherent difficulty of predicting the
outcome of such matters, the Company cannot state what the eventual outcome of
these matters will be. However, based on current knowledge and after
consultation with legal counsel, management believes that in accordance with
SFAS No. 5, "Accounting for Contingencies" (SFAS 5), the amount of any
incremental liability arising from these matters is not expected to have a
material adverse effect on the Company's consolidated financial condition or
results of operations.

         On August 17, 2007 the Ohio Department of Commerce, Division of
Securities entered a cease and desist order against Medical Connections, Inc.
("MCI") (Order No. 06-241) prohibiting MCI from selling unregistered securities.
The order was issued in connection with the sale of MCI securities to two
different investors in the state of Ohio. While MCI believes that it has a
meritorious defense on appeal under Section 1707.03()) of the Ohio Revised Code,
management made the decision to accept the order as proposed by the Department
of Commerce as the appeals would take time, divert management's attention from
the day to day operations, and result in significant legal expense. The alleged
violations occurred in October 2005, prior to the acquisition of MCI by Medical
Connections Holdings, Inc.

Item 2.  Management's Discussion and Analysis of Financial Condition and
         Results of Operations

                  CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

         Certain statements in this quarterly report on Form 10-QSB contain or
may contain forward-looking statements that are subject to known and unknown
risks, uncertainties and other factors which may cause actual results,
performance or achievements to be materially different from any future results,
performance or achievements expressed or implied by such forward-looking
statements. These forward-looking statements were based on various factors and
were derived utilizing numerous assumptions and other factors that could cause
our actual results to differ materially from those in the forward-looking
statements. These factors include, but are not limited to, economic, political
and market conditions and fluctuations, government and industry regulation,
interest rate risk, U.S. and global competition, and other factors. Most of
these factors are difficult to predict accurately and are generally beyond our
control. You should consider the areas of risk described in connection with any
forward-looking statements that may be made herein. Readers are cautioned not to
place undue reliance on these forward-looking statements, which speak only as of
the date of this report. Readers should carefully review this quarterly report
in its entirety, including but not limited to our financial statements and the
notes thereto. Except for our ongoing obligations to disclose material
information under the Federal securities laws, we undertake no obligation to
release publicly any revisions to any forward-looking statements, to report
events or to report the occurrence of unanticipated events. For any
forward-looking statements contained in any document, we claim the protection of
the safe harbor for forward-looking statements contained in the Private
Securities Litigation Reform Act of 1995.

                                       12
<PAGE>

Background

About Medical Connections:

         Medical Connections is a national provider of medical recruitment and
staffing services. Established in 2002 to satisfy the increasing need for
qualified healthcare professionals, the Company's business is to identify,
select and place the best nurses, allied health specialists, pharmacists,
physicians and hospital management executives. The Company provides recruiting
and staffing services for permanent and temporary positions, with an option for
the clients and candidates to decide the best formula for working together.
Following the changing dynamics of the healthcare recruiting market, Medical
Connections has shifted its niche to emphasize the recruiting of allied health
specialists.

COMPARISON OF OPERATING RESULTS FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2007 TO
THE NINE MONTHS ENDED SEPTEMBER 30, 2006

Revenues and Expenses

         For the nine months ended September 30, 2007 as compared to the nine
months ended September 30, 2006, we had revenues of $ 3,255,643 as compared to $
1,415,487, an increase of $1,840,156 or 130 %. The primary reason for this
increase in revenues is a growing number of medical placements, as a result of
our increased marketing and advertising efforts. As our operations have
expanded, an increasing number of medical professionals have sought to utilize
our services. With a growing presence in the medical staffing community, we have
also been able to secure contracts from medical facilities which were not
previously available to us. As of September 30, 2007, we have 38 medical
professionals, available for travel positions, an increase from 19 medical
professionals, as of September 30, 2006. These increases have led to the
increase in revenues. We have also increased our client base over the past year.

Operating Expenses

            For the nine months ended September 30, 2007 as compared to the nine
months ended September 30, 2006, our total operating expenses increased from
$3,109,903 to $7,029,747, an increase of $ 3,919,844 or 126%. Our most
significant expenses are directly related to our staffing requirements,
consisting of our administrative staff and our contract (travel) health service
staff. Our payroll expense increased from $1,940,713 for the nine months ended
September 30, 2006 to $3,570,784 for the nine months ended September 30, 2007.
We recorded direct costs related to our staffing compensation and relocation of
$1,842,687 for the nine months ended September 30, 2007 compared to $439,086 for
the nine months ended September 30, 2006. We expect payroll staffing and
employee related expenses to continue to increase as our operations increase.

         We incurred $ 797,178 in interest expense for the nine months ended
September 30, 2007 as compared to $243,311 for the comparable period in 2006.
The majority of this expense is attributable to our borrowing costs associated
with the convertible debentures that we have issued.

         Our advertising costs increased from $154,102 for the nine months ended
September 30, 2006 to $278,173 for the nine months ended September 30, 2007. Our
administrative expenses increased from $184,175 for the nine months ended
September 30, 2006 to $452,643 for the nine months ended September 30, 2007. We
increased our advertising and marketing efforts to attract additional business.

         Our (loss) from operations increased, as a result of the previously
mentioned increases of expenses. It was $(3,774,104) for the nine months ended
September 30, 2007 as compared to operating losses totaling $(1,694,416) for the
nine months ended September 30, 2006. Our basic loss per share for the nine
months ended September 30, 2007 was $(0.46) as compared to a basic loss per
share of $(2.22) for the nine months ended September 30, 2006. The principal
reason for the significant decrease in our net loss per share, was due to an
increase in the weighted average number of shares outstanding. The Company's
loss increased, primarily, as a result of expansion of the business, including
hiring of additional recruiters. Management believes this strategy will lead to
more revenue. As operations grow, name recognition and recurring agreements with
existing clients should help reduce operating costs. However, there can be no
assurance that this will be the case. The Company will require additional


                                       13
<PAGE>

financing to continue as a going concern. There can be no assurance the Company
will be able to continue to obtain additional financing.

COMPARISON OF OPERATING RESULTS FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2007 TO
THE THREE MONTHS ENDED SEPTEMBER 30, 2006

Revenues and Expenses

         For the three months ended September 30, 2007 as compared to the three
months ended September 30, 2006, we had revenues of $ 1,176,850 as compared to $
745,635, an increase of $ 431,215 or 58%. The primary reasons for this increase
in revenues are a growing number of medical placements, as a result of our
increased advertising and marketing efforts. As our operations have expanded, an
increasing number of medical professionals have sought to utilize our services.
With a growing presence in the medical staffing community, we have also been
able to secure contracts from medical facilities which were not previously
available to us. As the business has grown, revenue has grown, to reflect the
growth of the business. As of September 30, 2007, we have 38 medical
professionals, available for travel positions, an increase from 32 medical
professionals, as of June 30, 2007, and an increase from 19 medical
professionals, as of September 30, 2006. These increases should increase our
revenues. We have also increased our client base over the past year.

Operating Expenses

         Our total operating expenses increased from $1,204,692 for the three
months ended September 30, 2006 to $2,502,995 for the three months ended
September 30, 2007. Our most significant expenses are directly related to our
staffing requirements. Our payroll expense increased from $633,539 for the three
months ended September 30, 2006 to $1,119,937 for the three months ended
September 30, 2007. Our total costs, related to our staffing compensation and
relocation, increased from $ 302,135 for the three months ended September 30,
2006 to $642,597 for the three months ended September 30, 2007. We expect
payroll and employee related expenses to continue to increase as our operations
increase.

         We incurred $305,804 in interest expense for the three months ended
September 30, 2007 as compared to $159,919 for the comparable period in 2006.
The majority of this expense, $187,275, is attributable to our borrowing costs
associated with the convertible debentures that we have issued.

         Our advertising costs increased from $60,271 for the three months ended
September 30, 2006 to $93,311 for the three months ended September 30, 2007 and
our administrative expenses increased from $85,271 for the three months ended
September 30, 2006 to $178,183 for the three months ended September 30, 2007.
These increases are attributable to our decision to allocate greater sums to
advertising now that we have increased revenues.

Net Loss

         Our loss from operations increased. It was $(1,326,145) for the three
months ended September 30, 2007 as compared to operating losses totaling
$(459,057) for the three months ended September 30, 2006. Our basic loss per
share for the three months ended September 30, 2007 was $(0.15) as compared to a
basic loss per share of $(0.25) for the three months ended September 30, 2006.
The principal reason, for the significant decrease, in our net loss per share,
was due to an increase, in the weighted average number of shares outstanding.

Liquidity and Capital Resources

         We use funds from operations to fund our business. In addition, we have
relied upon the sale of our stock and debentures offerings to fund operations.
Through the first nine months, of 2007, we have raised $ 5,050,275 in cash,
through common stock sales of convertible debentures. We also factor our
accounts receivable for contract (travel) invoices. Wells Fargo Business
Services purchases some of our contract (travel) invoices, initially for 90% of
the invoice price, sending a wire transfer within 48 hours, which helps our
liquidity, and cash flow. The remaining 10 % is part of a reserve, in which the
Company receives part of the 10%, depending upon Wells Fargo's costs related to
collections of accounts receivable. We use these funds for direct operating
expenses, as well as general and administrative purposes.

         As of September 30, 2007, we had cash of $1,313,072 and accounts
receivable of $493,729. Our total current assets were $1,806,801. On December
31, 2006, we had cash of $ 96,252 and accounts receivable of $ 238,878, as well


                                       14
<PAGE>

as current assets of $ 335,130. As the business has grown, assets such as cash
and accounts receivable have grown, to reflect the growth of the business. In
order to meet our cash needs, we were required to offer both convertible debt
and equity. As of September 30, 2007, we have property and equipment totaling
$270,920 less accumulated depreciation of $119,671 for a total of $151,249. On
December 31, 2006, we had property and equipment totaling $195,194 less
accumulated depreciation of $70,620 for a total of $124,574. Our company is
growing. We have hired more employees, and increased our quantity of furniture,
and computers. We also purchased a computer server, and now have all of our
employees, on a network, through the server. We also have an investment of $
647,432, in a home which the Company owns, in North Carolina. The Company is not
currently renting this house. As a result, management is trying to identify a
potential rental candidate to offset carrying costs or possibly selling the
property. Our total assets, on September 30, 2007, were recorded at a value of
$2,634,022. On December 31, 2006, our total assets were recorded at a value of
$1,135,676.

         As of September 30, 2007, we have current liabilities totaling
$4,327,726 which results in a working capital deficit (current assets less
current liabilities) of $2,520,925. The majority, of our outstanding current
liabilities, are the result of securities, which have been issued, or, which we
are obligated, to issue. Specifically, we currently owe $3,333,565 pursuant to
our outstanding convertible debt instruments, and have recorded $466,211 as a
derivative liability. These debt instruments will be due, and payable, at
various times, over the next twelve months. It is currently anticipated, that
the Company will satisfy its obligations, to the debenture holders, by issuing
them shares, of our common stock, at the lesser of a fixed conversion price, of
either $.75, or, 90% of the closing bid price, of the Company's common stock, on
the date of conversion. The issuance, of additional shares, of Common Stock,
will result in further dilution, to the shareholders. On December 31, 2006, we
had current liabilities totaling $1,643,092 which results in a working capital
deficit (current assets less current liabilities) of $1,307,962.

         As of September 30, 2007, our total liabilities are $3,856,018 and we
have an accumulated deficit of $16,216,902. On December 31, 2006, we had total
liabilities of $2,102,544 and an accumulated deficit of $11,782,197.

CRITICAL ACCOUNTING POLICIES

         Financial Reporting Release No. 60, which was released by the
Securities and Exchange Commission (the "SEC"), encourages all companies to
include a discussion of critical accounting policies or methods used in the
preparation of financial statements. The Company's condensed consolidated
financial statements include a summary of the significant accounting policies
and methods used in the preparation of the condensed consolidated financial
statements. Management believes the following critical accounting policies
affect the significant judgments and estimates used in the preparation of the
condensed consolidated financial statements.

         Use of Estimates - Management's discussion and analysis or plan of
operation is based upon the Company's condensed consolidated financial
statements, which have been prepared in accordance with accounting principles
generally accepted in the United States of America. The preparation of these
condensed consolidated financial statements requires management to make
estimates and judgments that affect the reported amounts of assets, liabilities,
revenues, and expenses, and related disclosure of contingent assets and
liabilities. On an ongoing basis, management evaluates these estimates,
including those related to allowances for doubtful accounts receivable and
long-lived assets. Management bases these estimates on historical experience and
on various other assumptions that are believed to be reasonable under the
circumstances, the results of which form the basis of making judgments about the
carrying value of assets and liabilities that are not readily apparent from
other sources. Actual results may differ from these estimates under different
assumptions or conditions.

         We review the carrying value of property and equipment for impairment
at least annually or whenever events or changes in circumstances indicate that
the carrying amount of an asset may not be recoverable. Recoverability of
long-lived assets is measured by comparison of its carrying amount to the
undiscounted cash flows that the asset or asset group is expected to generate.

         If such assets are considered to be impaired, the impairment to be
recognized is measured by the amount by which the carrying amount of the
property, if any, exceeds its fair market value.

         Effective January 1, 2006, we adopted the provisions of SFAS No.
123(R), "Share-Based Payment," under the modified prospective method. SFAS No.


                                       15
<PAGE>

123(R) eliminates accounting for share-based compensation transactions using the
intrinsic value method prescribed under APB Opinion No. 25, "Accounting for
Stock Issued to Employees," and requires instead that such transactions be
accounted for using a fair-value-based method. Under the modified prospective
method, we are required to recognize compensation cost for share-based payments
to employees based on their grant-date fair value from the beginning of the
fiscal period in which the recognition provisions are first applied. For periods
prior to adoption, the financial statements are unchanged, and the pro forma
disclosures previously required by SFAS No. 123, as amended by SFAS No. 148,
will continue to be required under SFAS No. 123(R) to the extent those amounts
differ from those in the Statement of Operations.

ITEM 3.  CONTROLS AND PROCEDURES.

         As of the end of the period covered by this Report, the Company's chief
executive officer and its principal financial officer (the "Certifying
Officers"), evaluated the effectiveness of the Company's "disclosure controls
and procedures," as defined in Rule 13a-15(e) under the Securities Exchange Act
of 1934. Based on that evaluation, the Certifying Officers concluded that, as of
the date of their evaluation, the Company's disclosure controls and procedures
were effective to provide reasonable assurance that information required to be
disclosed in the Company's periodic filings under the Securities Exchange Act of
1934 is accumulated and communicated to management, including these officers, to
allow timely decisions regarding required disclosure.

         The Certifying Officers have also indicated that there were no
significant changes in our internal controls or other factors that could
significantly affect such controls subsequent to the date of their evaluation
and there were no corrective actions with regard to significant deficiencies and
material weaknesses.

         Our management, including the Certifying Officers, does not expect that
our disclosure controls or our internal controls will prevent all errors and
fraud. A control system, no matter how well conceived and operated, can provide
only reasonable, not absolute, assurance that the objectives of the control
system are met. In addition, the design of a control system must reflect the
fact that there are resource constraints, and the benefits of controls must be
considered relative to their costs. Because of the inherent limitations in all
control systems, no evaluation of controls can provide absolute assurance that
all control issues and instances of fraud, if any, within a company have been
detected. These inherent limitations include the realities that judgments in
decision-making can be faulty, and that breakdowns can occur because of simple
error or mistake. Additionally, controls can be circumvented by the individual
acts of some persons, by collusion of two or more people or by management
override of the control. The design of any systems of controls also is based in
part upon certain assumptions about the likelihood of future events, and there
can be no assurance that any design will succeed in achieving its stated goals
under all potential future conditions. Because of these inherent limitations in
a cost-effective control system, misstatements due to error or fraud may occur
and not be detected.

         PART II. OTHER INFORMATION

Item 1. Legal Proceedings.

         On June 26, 2007, we were served with a complaint by a former employee.
The complaint involves several different workplace issues which led to her
termination. The complaint was filed in the Circuit Court in and for Palm Beach
County, Florida, case # 502007CA010062-MB. The Company has filed an action in
Broward County Circuit Court against the Plaintiff. Except as set forth herein
there have been no changes or developments in any legal proceedings which have
been filed against the Company. For a complete description of all legal
proceedings which are currently pending, you are urged to read our Form 10-KSB
which was filed with the Securities and Exchange Commission on April 12, 2007.

         Management believes that it has meritorious defenses to all asserted
claims. Nevertheless, if the current claims were adversely decided, management
does not believe that these claims will have an adverse affect on the Company's
operations.

         On August 17, 2007 the Ohio Department of Commerce, Division of
Securities entered a cease and desist order against Medical Connections, Inc.
("MCI") (Order No. 06-241) prohibiting MCI from selling unregistered securities.
The order was issued in connection with the sale of MCI securities to two


                                       16
<PAGE>

different investors in the state of Ohio. While MCI believes that it has a
meritorious defense on appeal under Section 1707.03()) of the Ohio Revised Code,
management made the decision to accept the order as proposed by the Department
of Commerce as the appeals would take time, divert management's attention from
the day to day operations, and result in significant legal expense. The alleged
violations occurred in October 2005, prior to the acquisition of MCI by Medical
Connections Holdings, Inc.

Item 2.  Unregistered Sales of Equity Securities

         During the quarter ended September 30, 2007 we issued the following
securities:

         At various dates, during the quarter, we issued a total of 1,697,367
shares of our Common Stock at a price of $1.00 per share to accredited
investors.

         On August 9, 2007 we issued 100,000 shares of our Common Stock to
certain employees for services rendered. The Common Stock was valued at $ 0.38
per share, the fair market value at the date of issuance. A charge of $38,000
has been included in the consolidated statement of operations for the nine
months ended September 30, 2007.

         On September 30, 2007 we issued 1,063,618 shares of our Common Stock to
convertible debenture holders in exchange for $797,713 of debt and interest.

         The securities issued in the foregoing transactions were made in
reliance upon an exemption from registration under Rule 701 promulgated under
Section 3(b) of the Securities Act and or Section 4(2) of the Securities Act.
Alternatively, these issuances of securities were undertaken under Rule 506 of
Regulation D under the Securities Act of 1933, as amended, by the fact that:

         - the sale was made to a sophisticated or accredited investor, as
defined in Rule 502;

         - we gave the purchaser the opportunity to ask questions and receive
answers concerning the terms and conditions of the offering and to obtain any
additional information which we possessed or could acquire without unreasonable
effort or expense that is necessary to verify the accuracy of information
furnished;

         - at a reasonable time prior to the sale of securities, we advised the
purchaser of the limitations on resale in the manner contained in Rule 502(d)2;
and

         - neither we nor any person acting on our behalf sold the securities by
any form of general solicitation or general advertising;

Item 3.  Defaults upon senior securities.

         None.

Item 4.  Submission of matters to a vote of security holders.

         There were no matters submitted during the quarter ended September 30,
2007 to a vote of the Company's securities holders.

Item 5.  Other information

         On September 21, 2007, the Company was listed in the Standard & Poor's
Market Access Program. This service includes profiles of the Company in Standard
& Poor's Corporation Records, Standard & Poor's Daily News, Standard & Poor's
MarketScope, and the Standard & Poor's Market Access Website, plus entry into
the Standard & Poor's Stock Guide Database.


                                       17
<PAGE>

Item 6.  Exhibits and Report on Form 8-K

         There were no reports filed on Form 8-K during the period covered by
this report.

EXHIBIT NO.    DESCRIPTION
-----------    -----------

31.1           Section 302 Certification of the Principal Executive Officer *

31.2           Section 302 Certification of the Principal Financial Officer *

32.1           Section 906 Certification of Principal Executive Officer *

32.2           Section 906 Certification of Principal Financial and Accounting
               Officer *
----------
* Filed herewith

                                       18
<PAGE>

                                   SIGNATURES

          In accordance with Section 13 or 15(d) of the Exchange Act, the
registrant caused this report to be signed on its behalf by the undersigned,
thereunto duly authorized.

                                            MEDICAL CONNECTIONS HOLDINGS, INC.

Date:  November 14, 2007


                                            By: /s/ Joseph Azzata
                                                -----------------
                                                Joseph Azzata,
                                                CEO and Director

         In accordance with the Exchange Act, this report has been signed below
by the following persons on behalf of the registrant and in the capacities and
on the dates indicated.


By: /s/ Joseph Azzata                                   Date:  November 14, 2007
    -----------------
    Joseph Azzata
    CEO/ Director


/s/ Brian Quillen                                       Date:  November 14, 2007
-----------------
Brian Quillen, CFO

                                       19